Private Equity

CVC Capital Partners joins Asia fundraising frenzy, inks $2.6B exit

CVC Capital Partners is restocking its coffers in two different ways: with a new $4 billion Asia fund and a $2.6 billion exit in Europe.

CVC Capital Partners has set a $4 billion target for its latest Asia fund, according to the Financial Times, joining a host of private equity investors raising huge pools of cash in the region. And the firm will be restocking its coffers in a different way, too: In a separate move, CVC has agreed to sell French chipmaker Linxens to Chinese state-owned Tsinghua Unigroup for €2.2 billion (about $2.6 billion), per Reuters, the latest big-money exit for the European buyout giant.

Several of CVC’s rivals have also been raising funds in Asia like never before. Last month, The Carlyle Group closed its latest effort in the region on $6.55 billion, its largest Asia fund ever. A week before that, Blackstone wrapped up a $2.3 billion Asia vehicle, and KKR closed a $9.3 billion Asian Fund III last year. Bain Capital is also believed to be gathering commitments for a multibillion-dollar pool to invest in the region, and Hong Kong-based Affinity Equity Partners raised a $6 billion fund earlier this year.

CVC’s new Asia fund will be the firm’s fifth, following a €2.55 billion predecessor from 2014. Just last June, meanwhile, the firm raised €16 billion for its seventh flagship buyout fund, the largest European vehicle of the decade, per the PitchBook Platform.

It’s back in Europe—France, to be precise—where CVC’s latest major sale is taking place. That’s the home base of Linxens, a maker of microconnectors, antennas, inlays and other chip components for clients in the security and identity industries. CVC has backed the company since 2015, when it acquired Linxens in an SBO from Astorg for a reported €1.5 billion.

The firm lined up an even larger sale earlier this year in the UK. In April, CVC signed a deal to sell its stake in Sky Betting & Gaming to The Stars Group, another gambling business, for $4.7 billion. Like with Linxens, CVC had acquired its initial stake in Sky Bet in 2015. Another major CVC exit may be looming in Malaysia, where the firm’s QSR Brands is believed to be mulling an IPO that could raise more than $500 million.

Huge funds, huge exits—what about huge new investments? CVC has been making those, too. Late last month, the firm agreed to take control of Recordati, an Italian pharmaceutical company that had been family owned for more than 90 years, in a deal that valued the business at nearly €5.9 billion. That was Europe’s largest pharmaceutical move by a private equity firm in at least 10 years, per PitchBook data.

We’ve got more on PE and VC in Europe.


Learn about our editorial standards.